Acute Lymphoblastic Leukemia In Relapse clinical trials

Explore recruiting acute lymphoblastic leukemia in relapse clinical trials.

Recruiting acute lymphoblastic leukemia in relapse studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Lymphoblastic Leukemia In Relapse trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies in children – sub protocol B

Netherlands, Spain, Norway, Sweden, Denmark, Germany +5 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies in children - Sub-protocol C

Denmark, Norway, Italy, Netherlands, Finland, Spain +5 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies in children - Sub-protocol D

Netherlands, Denmark, Finland, Germany, Italy, Spain +5 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Acute Lymphoblastic Leukemia In Relapse trials by city

Acute Lymphoblastic Leukemia In Relapse in Toronto Acute Lymphoblastic Leukemia In Relapse in Vancouver Acute Lymphoblastic Leukemia In Relapse in Montreal Acute Lymphoblastic Leukemia In Relapse in Calgary Acute Lymphoblastic Leukemia In Relapse in Edmonton Acute Lymphoblastic Leukemia In Relapse in Ottawa Acute Lymphoblastic Leukemia In Relapse in Winnipeg Acute Lymphoblastic Leukemia In Relapse in Quebec City Acute Lymphoblastic Leukemia In Relapse in Hamilton Acute Lymphoblastic Leukemia In Relapse in Kitchener Acute Lymphoblastic Leukemia In Relapse in London Acute Lymphoblastic Leukemia In Relapse in Halifax Acute Lymphoblastic Leukemia In Relapse in New York Acute Lymphoblastic Leukemia In Relapse in Los Angeles Acute Lymphoblastic Leukemia In Relapse in Chicago Acute Lymphoblastic Leukemia In Relapse in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease